Publications
Found 11 results
Filters: Author is A.M. Barbosa [Clear All Filters]
“CYP2C19*2 polymorphism influenced response to clopidogrel treatment but was not related to restenosis in atherosclerotic smokers”, Genetics and Molecular Research, vol. 19, no. 3, 2020.
, “Lack of association of restenosis with the T786C polymorphism of eNOS in atherosclerotic patients and in silico evidence of interaction between statin and the eNOS protein”, Gentetics and Molecular Research, vol. 19, no. 2, 2020.
, “The eNOS T786C polymorphism is not related to atherosclerosis and cofactors in a Brazilian population”, Genetics and Molecular Research, vol. 18, no. 3, 2019.
, “GSTT1 null genotype in sickle cell anemia and blood transfusion recurrence – a case report”, Genetics and Molecular Research, vol. 18, no. 2, 2019.
, “Polymorphisms of the genes eNOS, GSTT1 and GSTM1 are significantly associated with atherosclerotic disease in hypertensive patients”, Genetics and Molecular Research, vol. 18, no. 1, 2019.
, “RFLP-PCR is more efficient than ARMS-PCR for identifying CYP2C19*2 polymorphism in atherosclerotic patients”, Genetics and Molecular Research, vol. 18, no. 3, 2019.
, “Scientometric analysis: Five years of genetic polymorphisms”, Genetics And Molecular Research, vol. 17, no. 2, 2018.
, “Association of CYP1A1 (cytochrome P450) MspI polymorphism in women with endometriosis”, vol. 15, p. -, 2016.
, “Association of CYP1A1 (cytochrome P450) MspI polymorphism in women with endometriosis”, vol. 15, p. -, 2016.
, “GSTM1 and GSTT1 polymorphisms in endometriosis in women from Goiás, Brazil”, vol. 12, pp. 2764-2770, 2013.
, “GSTM1 polymorphism in patients with primary open-angle glaucoma”, vol. 11, pp. 3256-3262, 2012.
,
Abu-Amero KK, Morales J, Mohamed GH, Osman MN, et al. (2008). Glutathione S-transferase M1 and T1 polymorphisms in Arab glaucoma patients. Mol. Vis. 14: 425-430.
PMid:18334963 PMCid:2268859
Board PG, Baker RT, Chelvanayagam G and Jermiin LS (1997). Zeta, a novel class of glutathione transferases in a range of species from plants to humans. Biochem. J. 328: 929-935.
PMid:9396740 PMCid:1219006
Dias JFP and Almeida HG (2000). Glaucoma. 2ª ed. Cultura Médica, Rio de Janeiro.
Izzotti A, Bagnis A and Sacca SC (2006). The role of oxidative stress in glaucoma. Mutat. Res. 612: 105-114.
http://dx.doi.org/10.1016/j.mrrev.2005.11.001
PMid:16413223
Juronen E, Tasa G, Veromann S, Parts L, et al. (2000). Polymorphic glutathione S-transferase M1 is a risk factor of primary open-angle glaucoma among Estonians. Exp. Eye Res. 71: 447-452.
http://dx.doi.org/10.1006/exer.2000.0899
PMid:11040079
Kamal D and Hitchings R (1998). Normal tension glaucoma - a practical approach. Br. J. Ophthalmol. 82: 835-840.
http://dx.doi.org/10.1136/bjo.82.7.835
PMid:9924383 PMCid:1722650
Kanski JJ (2003). Oftalmologia Clínica: Uma Abordagem Sistemática. 5ª ed. Elsevier, Rio de Janeiro.
Katoh T, Yamano Y, Tsuji M and Watanabe M (2008). Genetic polymorphisms of human cytosol glutathione S-transferases and prostate cancer. Pharmacogenomics 9: 93-104.
http://dx.doi.org/10.2217/14622416.9.1.93
PMid:18154451
Leske MC (1983). The epidemiology of open-angle glaucoma: a review. Am. J. Epidemiol. 118: 166-191.
PMid:6349332
Marigo FA, Cronemberger S and Calixto N (2001). Neuroproteção: situação atual no glaucoma. Arq. Bras. Oftalmol. 64: 167-171.
http://dx.doi.org/10.1590/S0004-27492001000200016
Quigley HA (1996). Number of people with glaucoma worldwide. Br. J. Ophthalmol. 80: 389-393.
http://dx.doi.org/10.1136/bjo.80.5.389
PMid:8695555 PMCid:505485
Quigley HA and Broman AT (2006). The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90: 262-267.
http://dx.doi.org/10.1136/bjo.2005.081224
PMid:16488940 PMCid:1856963
Quigley HA, Nickells RW, Kerrigan LA, Pease ME, et al. (1995). Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest. Ophthalmol. Vis. Sci. 36: 774-786.
PMid:7706025
Racette L, Wilson MR, Zangwill LM, Weinreb RN, et al. (2003). Primary open-angle glaucoma in blacks: a review. Surv. Ophthalmol. 48: 295-313.
http://dx.doi.org/10.1016/S0039-6257(03)00028-6
Rebbeck TR (1997). Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. 6: 733-743.
PMid:9298582
Ritch R, Shields MB and Krupin T (1996). The Glaucomas. Basic Sciences Vol. 1. 2nd edn. Mosby - Year Book, St. Louis.
Sarfarazi M, Akarsu AN, Hossain A, Turacli ME, et al. (1995). Assignment of a locus (GLC3A) for primary congenital glaucoma (Buphthalmos) to 2p21 and evidence for genetic heterogeneity. Genomics 30: 171-177.
http://dx.doi.org/10.1006/geno.1995.9888
PMid:8586416
Uhm KB and Shin DH (1992). Positive family history of glaucoma is a risk factor for increased IOP rather than glaucomatous optic nerve damage (POAG vs OH vs normal control). Korean J. Ophthalmol. 6: 100-104.
PMid:1301446
Unal M, Guven M, Devranoglu K, Ozaydin A, et al. (2007). Glutathione S transferase M1 and T1 genetic polymorphisms are related to the risk of primary open-angle glaucoma: a study in a Turkish population. Br. J. Ophthalmol. 91: 527-530.
http://dx.doi.org/10.1136/bjo.2006.102418
PMid:16973661 PMCid:1994754
Wiggs JL (2007). Genetic etiologies of glaucoma. Arch. Ophthalmol. 125: 30-37.
http://dx.doi.org/10.1001/archopht.125.1.30
PMid:17210849